Research location
Pamplona
Pamplona, Spain
Advertisement
Research activity in Pamplona
Pamplona, SpainCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Pamplona
9 linked trials · page 1 of 1Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC)NCT07153445 · 2025-07-08 · 1 site observation
RECRUITING
Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung CancerNCT05384015 · 2022-11-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung CancerNCT05403385 · 2022-08-26 · 1 site observation
ACTIVE_NOT_RECRUITING
New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapyNCT04564157 · 2021-01-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesNCT01618370 · 2012-07-22 · 1 site observation
COMPLETED
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung CancerNCT00707304 · 2008-11-01 · 1 site observation
COMPLETED
A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal MetastasesNCT00699751 · 2008-06-12 · 1 site observation
COMPLETED
Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy VolunteersNCT00656825 · 2007-03-01 · 1 site observation
COMPLETED
Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once DailyNCT00314626 · 2004-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.